GlassScriptPhysician profile
Amanda M Bear
NPI 1649529884
$20,784.10
in general payments reported to CMS, 2019-2025
68 companies · $5,429 in 2025
The $5,429 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,416 · 2022: $3,557 · 2023: $3,912 · 2024: $4,470 · 2025: $5,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $795 · Education: $49.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,967.16 |
| Consulting Fee | $795.00 |
| Education | $49.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,873.75 | 2021-2025 | |
| Lundbeck LLC | $1,611.71 | 2021-2025 | Vyepti, Rexulti |
| Jazz Pharmaceuticals INC. | $1,584.52 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,381.40 | 2021-2025 | |
| Pfizer INC. | $1,283.56 | 2021-2025 | |
| Lilly USA, LLC | $1,227.55 | 2022-2025 | Kisunla, Amyvid, Emgality |
| Sk Life Science, INC. | $877.03 | 2021-2025 | Xcopri |
| Eisai INC. | $697.26 | 2021-2025 | |
| Genentech USA, INC. | $526.14 | 2021-2025 | Ocrevus, Ocrevus Zunovo |
| Biogen, INC. | $523.57 | 2021-2025 | Vumerity, Tysabri, Skyclarys |
| Axsome Therapeutics, INC. | $507.38 | 2023-2025 | Symbravo, Sunosi |
| Teva Pharmaceuticals USA, INC. | $499.95 | 2021-2025 | Ajovy, Austedo Xr, Austedo |
| Impel Pharmaceuticals INC. | $494.83 | 2022-2023 | Trudhesa |
| Ucb, INC. | $451.67 | 2021-2025 | Briviact, Nayzilam, Zilbrysq |
| Amgen INC. | $437.23 | 2021-2025 | Uplizna |
Show all 68 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Bear listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.